Report calls for urgent action to drive down surgical site infections
The ‘Time to Act’ report has highlighted that one in 20 patients who undergo a surgical procedure in the NHS contract a surgical site...
Hope for UK to return to “normal” with new NHS Test and Trace strategy
In a bid to protect people’s health and continue to limit the spread of the COVID-19 virus, a new strategy for the NHS test...
European public services overspending on technology
New research has shown that European Public Service organisations are overspending on technology.
New research from Insight has shown that 94% of European public service...
NHS hospitals to receive £600m for refurbishment
Funding of £600m will be provided to NHS Trusts across the country for refurbishment.
Staff, patients, and visitors across all regions in England will be...
Leading causes of death worldwide revealed by WHO
The World Health Organization has revealed that noncommunicable diseases now make up seven of the world’s top 10 causes of death worldwide.
The WHO’s 2019...
Chemotherapy-free treatment for Chronic Lymphocytic Leukaemia patients
For the first time, patients in Scotland with previously untreated Chronic Lymphocytic Leukaemia will be able to access chemotherapy-free treatment.
The Scottish Medicines Consortium has...
Confidence in AI for improving patient outcomes in endoscopy grows
A new survey has shown that gastroenterology clinicians strongly support AI in endoscopy to deliver improved outcomes for patients.
A survey of endoscopists, GI nurses,...
Assessing impact of international travel restrictions on COVID-19 spread
The first study to assess the global impact of international travel restrictions on the COVID-19 pandemic has suggested that they may only be effective...
COVID-19 Oxford vaccine found safe and effective in Phase III trial
The first full results from the Phase III Oxford COVID-19 vaccine have found it to be safe and effective to protect against the virus.
The...
Clinical perceptions of AI in endoscopy
In this article, Mat Tallis, European Business Manager at Fujifilm Europe discusses the clinical perceptions of Artificial Intelligence (AI) in endoscopy.
We often hear about...
Research shows one in five people with multiple sclerosis now under 30
New research from the MS Society has revealed that one in five people diagnosed with Multiple Sclerosis are now under the age of 30.
The...
Smart phone camera adapted to detect presence of SARS-CoV-2
Researchers have developed an innovative way of detecting the presence of SARS-CoV-2 in a nasal swab using a device attached to an ordinary smartphone.
Senior...
First ever patient to receive COVID-19 vaccination in the UK
Today marks a landmark moment for the United Kingdom as the first NHS patient has received the Pfizer/BioNTech COVID-19 vaccine.
The biggest vaccination campaign in...
Meningococcus B vaccine shows 79% effectiveness
A vaccine for the deadly Meningococcus B has been shown to have 79% effectiveness in patients under the age of 18.
Meningococcus group B is...
Call for urgent review of European prostate cancer care
A group of experts have called for an urgent review of prostate cancer care in Europe following the results of a first of its...
Alleviating radiology backlogs with Artificial Intelligence
Before the COVID-19 pandemic, a chronic shortage of imaging equipment and skilled radiologists meant that hospitals had been plagued with a growing patient backlog...
House of Representatives votes to decriminalise cannabis at federal level
The US House of Representatives has voted for a bill that would decriminalise cannabis at the federal level.
In a bid to repair the damage...
Over half a million Brits participating in COVID-19 research
Over half a million British people have taken part in pioneering health research into COVID-19 over the last eight months.
The UK has been conducting...
COVID-19 vaccine added to damages scheme in case of severe disability
The UK has taken the precautionary measure of adding COVID-19 to its Vaccine Damage Payments Scheme so people will be able to access financial...
Increased risk of dying for rare autoimmune patients during COVID-19
A new study has shown that people living with rare autoimmune diseases are at heightened risk of dying during COVID-19, a finding that can...